CNO Financial Group Reports Third Quarter 2026 Results

(NYSE:CNO) CNO Financial Group, Inc. reported third quarter 2026 financial results, raising its 2026 operating earnings per share (EPS) guidance with the midpoint up 9% from prior guidance. Net income for the quarter was $161 million, or $1.71 per diluted share, while net operating income was $179 million, or $1.90 per diluted share. Significant items related to the comprehensive annual actuarial review had a $44.9 million net favorable impact on both net income and net operating income. Operating EPS grew 47% in the quarter and 43% year-to-date. Return on equity (ROE) was 16.4%, and operating ROE, excluding significant items, was 14.1%. Book value per share was $25.34, and book value per diluted share, excluding accumulated other comprehensive loss, was $41.29, up 8%. Total new annualized premiums (NAP) increased for the 17th consecutive quarter, and both Consumer and Worksite segments delivered their 15th and 17th consecutive quarters of producing agent count growth, respectively. On October 1, 2026, CNO closed its third reinsurance transaction with its wholly owned Bermuda affiliate, reinsuring approximately $270 million of inforce graded benefit life statutory reserves from Colonial Penn. Net realized investment losses in 3Q26 were $48.3 million, including an unfavorable change in the allowance for credit losses of $5.4 million. During 3Q26, the company recognized a decrease in earnings of $16.4 million due to the net change in market value of investments and an increase in earnings of $69.7 million from changes in the estimated fair value of embedded derivative liabilities and market risk benefits. Expenses related to the TechMod technology modernization initiative were $10.1 million in 3Q26. The company repurchased $60.0 million of common stock during the quarter, buying 1.1 million shares at an average cost of $54.52 per share. As of September 30, 2026, CNO had 91.7 million shares outstanding and authority to repurchase up to an additional $240.4 million of common stock. Dividends paid on common stock totaled $16.5 million in 3Q26. Unrestricted cash and investments held by the holding company were $230.7 million at September 30, 2026. The consolidated statutory risk-based capital ratio of U.S.-based insurance subsidiaries was estimated at 374% at September 30, 2026, reflecting an estimated 3Q26 statutory operating gain of $21.9 million. The debt-to-capital ratio was 36.5% at September 30, 2026, and the debt-to-total capital ratio, excluding accumulated other comprehensive income (loss), was 25.7%.

California Nanotechnologies Announces Production Orders from Texas-Based Aerospace Company Following Successful R&D

(TSXV:CNO, OTCID:CANOF) California Nanotechnologies Corp. announced that it has received several purchase orders totaling US$147,000 from a Texas-based aerospace company. These orders mark the transition of a research and development (R&D) program into commercial production for specialized components used in commercial satellite systems. The new production orders follow approximately US$170,000 in R&D manufacturing service orders received from the same customer during calendar 2026. Of the US$147,000 in new orders, US$114,750 represents about three months of production, which equates to an annualized production rate of approximately US$459,000 at current pricing and volumes. The company has been working with this aerospace client for about a year on R&D before moving into recurring production orders. Core technologies to be utilized include powder milling, spark plasma sintering (SPS), and post processing. The customer application is described as unique and demonstrates Cal Nano's ability to deliver next-generation products. Based on the customer's current forecast, production volumes could approximately double by the end of calendar 2027, representing a potential annualized production rate of approximately US$918,000 at current pricing, subject to customer demand and additional purchase orders. Eric Eyerman, CEO, commented on the successful transition from R&D to production and highlighted the use of core technologies. The company operates two manufacturing facilities in Greater Los Angeles, California, and serves customers ranging from Fortune 500 companies to startups in sectors such as aerospace, renewable energy, defense, and semiconductors.

California Nanotechnologies Announces Amended Lease to Expand Santa Ana Manufacturing Facility Capacity

(TSXV:CNO) (OTCID:CANOF) California Nanotechnologies Corp. has signed an amendment to its existing Santa Ana facility lease to support its manufacturing capacity expansion. The lease amendment adds an additional 15,500 square feet of adjacent space, which represents an approximate 80% increase to the company's existing 19,500 square foot footprint. The amendment also provides access to increased electrical current capacity to power the company's core technologies and other equipment. Eric Eyerman, CEO, stated that the lease amendment is timely as the company looks to expand production capacity for customers, referencing a recent large purchase order and a new development agreement with a Fortune 100 multinational. The expanded facility will offer larger floor and office space, loading docks, electrical capacity, and storage, which are key logistical components for scaling up operations. The new lease will take effect on November 1, 2026, and will incur an additional cost of approximately US$22,500 per month. Earlier in the fiscal year, the company consolidated its Cerritos facility into Santa Ana, resulting in approximately US$10,000 per month in savings. The company is headquartered in Greater Los Angeles, California, and operates advanced processing and testing machinery across two manufacturing facilities. Its customers include Fortune 500 companies and startups in sectors such as aerospace, renewable energy, defense, and semiconductors.

CNO Financial Group to Host Virtual Investor Briefing on Tuesday, September 1, 2026

(NYSE: CNO) CNO Financial Group, Inc. announced it will host a virtual investor briefing focused on its Worksite Division and Medicare business on Tuesday, September 1, 2026, from 10:00 a.m. to approximately 11:15 a.m. Eastern Time. The briefing will feature presentations on market opportunities, growth strategies and business fundamentals, along with interactive Q&A sessions with Worksite Division President Karen DeToro, Consumer Division President Scott Goldberg, Chief Actuary Jeremy Williams and other members of senior management. CNO Financial Group, Inc. provides life and health insurance, annuities and financial services through its brands, including Bankers Life, Colonial Penn, Optavise and Washington National. The company serves customers with 3.3 million policies and $39.9 billion in total assets. CNO Financial Group, Inc. employs 3,200 associates, 5,100 exclusive agents and more than 6,500 independent partner agents. This briefing represents the third installment in the investor briefing series, with prior sessions covering the Consumer Division and Investments function. A replay of the webcast will be available on the Investors section of the company's website at ir.CNOinc.com.

CNO Financial Group Declares $0.18 Quarterly Dividend

(NYSE: CNO) CNO Financial Group, Inc. announced that its Board of Directors has declared a quarterly cash dividend of $0.18 per share on the company's common shares. This marks the 58th consecutive quarterly dividend paid by the company. The dividend will be payable September 24, 2026, to shareholders of record at the close of business on September 10, 2026. CNO Financial Group, Inc. provides life and health insurance, annuities and financial services through its family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. The company serves customers with 3.3 million policies and $39.9 billion in total assets. CNO Financial Group, Inc. employs 3,200 associates, 5,100 exclusive agents and more than 6,500 independent partner agents.

CNO Financial Group Reports Second Quarter 2026 Results

(NYSE: CNO) CNO Financial Group, Inc. reported its second quarter 2026 financial results, with net income of $126 million, or $1.33 per diluted share, and net operating income of $120 million, or $1.26 per diluted share. Operating EPS grew 45% in the quarter and 39% year-to-date, while return on equity (ROE) was 10.9% and operating ROE, excluding significant items, was 13.1%. Book value per share was $27.96 and book value per diluted share, excluding accumulated other comprehensive loss, was $39.92, up 5%. Total new annualized premiums (NAP) increased 7%, marking 16 consecutive quarters of insurance sales growth, and quarterly records were achieved in Worksite Division NAP, annuity collected premiums, and client assets in brokerage and advisory. The company repurchased $60.0 million of common stock during 2Q26, with 1.3 million shares repurchased at an average cost of $46.57 per share, and paid $16.8 million in dividends on common stock. Unrestricted cash and investments held by the holding company were $233.2 million at June 30, 2026, compared to $351.4 million at December 31, 2025. The company projects full-year guidance on operating earnings per share to increase by 8% at the midpoint from prior guidance.

California Nanotechnologies Announces Q1 2027 Results

(TSXV:CNO) California Nanotechnologies Corp. announced revenues of US$917,854 for the quarter ended May 31, 2026, representing an increase of 28% compared to the prior year. Adjusted EBITDA 1 was a loss of US$129,031 for the fiscal quarter ended May 31, 2026, compared with a loss of US$152,707 in the prior year. Net loss for the fiscal quarter was US$449,598, compared to a net loss of US$447,887 in the prior fiscal year. The gross margin for the quarter was 45%, a decrease from 57% in the prior year, reflecting a lower manufacturing gross margin and a different sales mix with the one equipment sale valued at US$180,923. Diluted loss per share for the fiscal year was $0.01 compared to diluted loss per share of $0.01 for the same period last year. The company continues to anticipate, that if revenues increase, gross margin is expected to improve because its fixed costs and overhead would be spread over a larger revenue base. FY2027 is expected to build on these efforts with an emphasis on securing larger-scale manufacturing contracts, non-dilutive funding, and long-term partnerships to scale-up the Company's operations.

California Nanotechnologies Announces Stock Options

(TSXV:CNO) California Nanotechnologies Corp. announced it has granted 1,500,000 incentive stock options to the employees, directors and officers of the Company. The options were granted at an exercise price of $0.35 CAD per share, representing the closing price on July 2, 2026. The stock options will vest over three years and expire after a five-year period from July 3, 2026. The options are subject to TSX Venture Exchange requirements. Cal Nano hosts advanced processing and testing machinery and capabilities across two manufacturing facilities for materials research and production needs. The company serves customers ranging from Fortune 500 companies to startups with programs spanning aerospace, renewable energy, defense, and semiconductors. Eric Eyerman is listed as CEO of California Nanotechnologies Corp.

California Nanotechnologies Announces FY2026 Results

(TSXV:CNO) California Nanotechnologies Corp. announced revenues of US$2,788,642 for the fiscal year ending February 28, 2026, representing a decrease of 55% compared to the prior year. Manufacturing service revenues, excluding the green steel client, increased 85% year-over-year to US$2,626,894, and no single customer represented more than 10% of revenues. Adjusted EBITDA decreased to negative US$651,614 for the fiscal year, compared to positive US$2,558,516 in the prior year, while Q4/FY2026 Adjusted EBITDA was US$50,329, marking the first positive EBITDA quarter of the year. Net loss for the fiscal year was US$1,857,327, compared to net income of US$158,333 in the prior year, and diluted loss per share was ($0.04) versus $0.00 last year. The company closed a non-brokered private placement raising gross proceeds of CA$935,900 subsequent to year end. The company received its first purchase orders for reactor components on November 5, 2025, and has since received follow-on orders from the same customer. The company anticipates that if revenues increase, gross margin should improve because its fixed costs and overhead would be spread over a larger revenue base.

CNO Financial Group Extends Title Sponsorship of Indianapolis Monumental Marathon Through 2028

(NYSE:CNO) CNO Financial Group announced a multi-year extension of its title sponsorship of the CNO Financial Indianapolis Monumental Marathon through 2028. Since 2016, CNO has served as title sponsor of the marathon, half marathon and 5K, partnering with Beyond Monumental, the 501(c)3 nonprofit responsible for the event. The 2025 event marked the 13 th consecutive sellout, with a field of more than 17,500 participants—the largest in its history. Participants represented all 50 states and 22 countries. CNO Financial Group provides life and health insurance, annuities and financial services through its brands, with 3.3 million policies and $39 billion in total assets. The company has 3,300 associates, 5,000 exclusive agents and more than 7,500 independent partner agents. The 19 th annual running is scheduled for Nov. 7, 2026.

CNO Financial Group Announces Increase of Quarterly Dividend to $0.18

CNO Financial Group, Inc. (NYSE: CNO) announced that its Board of Directors has approved a $0.01 per share increase in its quarterly dividend, marking the 14th consecutive annual increase. The Board declared a quarterly cash dividend of $0.18 per share on the company's common shares. The dividend will be payable on June 24, 2026, to shareholders of record at the close of business on June 10, 2026. CNO Financial Group provides life and health insurance, annuities, and financial services through its family of brands. The company serves customers with 3.3 million policies and $39 billion in total assets.

CNO Financial Group Reports First Quarter 2026 Results

CNO Financial Group, Inc. (NYSE: CNO) reported its first quarter 2026 financial results, highlighting net income of $38 million ($0.39 per diluted share) and net operating income of $101 million ($1.05 per diluted share). Operating earnings per share grew 33%, and total new annualized premiums increased by 11%. The company reported a return on equity (ROE) of 9.5% and an operating ROE of 12.2%, excluding significant items. CNO repurchased $60.0 million of common stock and paid $17.1 million in dividends during the quarter. These results reflect continued sales momentum and disciplined execution, which are important for investors monitoring growth and capital management.